Virtus Investment Advisers, Inc. - HAEMONETICS CORP ownership

HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q4 2022. The put-call ratio across all filers is 3.00 and the average weighting 0.1%.

Quarter-by-quarter ownership
Virtus Investment Advisers, Inc. ownership history of HAEMONETICS CORP
ValueSharesWeighting
Q3 2023$1,223,842
+5.2%
13,6620.0%0.83%
+5.4%
Q2 2023$1,163,183
+2.9%
13,6620.0%0.79%
-0.3%
Q1 2023$1,130,531
+143.0%
13,662
+130.9%
0.79%
+155.5%
Q4 2022$465,293
+6.2%
5,9160.0%0.31%
+54.2%
Q3 2022$438,0005,9160.20%
Other shareholders
HAEMONETICS CORP shareholders Q4 2022
NameSharesValueWeighting ↓
BEACONLIGHT CAPITAL, LLC 95,033$8,511,0002.84%
Advantage Alpha Capital Partners LP 100,170$8,971,0002.10%
Nitorum Capital, L.P. 395,635$35,433,0001.82%
Summit Creek Advisors LLC 127,600$11,428,0001.68%
Bridge City Capital, LLC 40,559$3,632,0001.67%
AEGON ASSET MANAGEMENT UK PLC 520,408$46,603,0001.05%
Jackson Square Partners, LLC 2,298,190$205,825,0001.03%
Parkman Healthcare Partners LLC 30,147$2,700,0000.76%
TEALWOOD ASSET MANAGEMENT INC 9,154$820,0000.54%
AMERICAN CAPITAL MANAGEMENT INC 159,145$14,253,0000.52%
View complete list of HAEMONETICS CORP shareholders